Skip to main content
Erschienen in: European Journal of Nutrition 2/2013

01.03.2013 | Original Contribution

Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats

verfasst von: Su-Ching Yang, Hsin-Yi Yang, Yi-Ching Yang, Hsiang-Chi Peng, Pei-Yin Ho

Erschienen in: European Journal of Nutrition | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hypertension is one of the main factors causing cardiovascular diseases. The aim of the study is to investigate the effects of Chlorella pyrenoidosa on blood pressure and cardiorenal remodeling in rats with N ω-nitro-l-arginine methyl ester hydrochloride (L-NAME)-induced endothelial dysfunction.

Methods

Rats were fed a diet containing L-NAME (40 mg/kg) with or without chlorella (4 or 8 %) for 5 weeks. We found that chlorella retarded the development of hypertension and cardiorenal remodeling during the 5-week experimental period.

Results

Although there was no difference in NO x levels or plasma arginine concentrations, plasma and tissues ACE activities were significantly lower in the chlorella groups than in the L-NAME group. Moreover, tissue tumor necrosis factor-α concentrations and renal CYP4A expression were also lower in the chlorella group.

Conclusion

These results suggest that chlorella might ameliorate the elevation of blood pressure and show cardiorenal-protective effects in nitric oxide-deficient rats, and one possible mechanism might be mediated by its ACE inhibitory activity.
Literatur
1.
Zurück zum Zitat Taddei S, Virdis A, Mattei P et al (1996) Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94:1298–1303CrossRef Taddei S, Virdis A, Mattei P et al (1996) Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94:1298–1303CrossRef
2.
Zurück zum Zitat Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R (1992) Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20:298–303CrossRef Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R (1992) Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20:298–303CrossRef
3.
Zurück zum Zitat Ceconi C, Fox KM, Remme WJ et al (2007) ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 73:237–246CrossRef Ceconi C, Fox KM, Remme WJ et al (2007) ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 73:237–246CrossRef
4.
Zurück zum Zitat Miranda MS, Sato S, Mancini-Filho J (2001) Antioxidant activity of the microalga Chlorella vulgaris cultered on special conditions. Boll Chim Farm 140:165–168 Miranda MS, Sato S, Mancini-Filho J (2001) Antioxidant activity of the microalga Chlorella vulgaris cultered on special conditions. Boll Chim Farm 140:165–168
5.
Zurück zum Zitat Sansawa H, Takahashi M, Tsuchikura S, Endo H (2006) Effect of chlorella and its fractions on blood pressure, cerebral stroke lesions, and life-span in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 52:457–466CrossRef Sansawa H, Takahashi M, Tsuchikura S, Endo H (2006) Effect of chlorella and its fractions on blood pressure, cerebral stroke lesions, and life-span in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 52:457–466CrossRef
6.
Zurück zum Zitat Merchant RE, Andre CA, Sica DA (2002) Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food 5:141–152CrossRef Merchant RE, Andre CA, Sica DA (2002) Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food 5:141–152CrossRef
7.
Zurück zum Zitat Griesmacher A, Kindhauser M, Andert SE et al (1995) Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469–475CrossRef Griesmacher A, Kindhauser M, Andert SE et al (1995) Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469–475CrossRef
8.
Zurück zum Zitat Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71CrossRef Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71CrossRef
9.
Zurück zum Zitat Shalaby SM, Zakora M, Otte J (2006) Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. J Dairy Res 73:178–186CrossRef Shalaby SM, Zakora M, Otte J (2006) Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. J Dairy Res 73:178–186CrossRef
10.
Zurück zum Zitat Palm F, Nordquist L (2011) Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol 301:R1229–R1241CrossRef Palm F, Nordquist L (2011) Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol 301:R1229–R1241CrossRef
11.
Zurück zum Zitat Sugamura K, Keaney JF Jr (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51:978–992CrossRef Sugamura K, Keaney JF Jr (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51:978–992CrossRef
12.
Zurück zum Zitat Vijayavel K, Anbuselvam C, Balasubramanian MP (2007) Antioxidant effect of the marine algae Chlorella vulgaris against naphthalene-induced oxidative stress in the albino rats. Mol Cell Biochem 303:39–44CrossRef Vijayavel K, Anbuselvam C, Balasubramanian MP (2007) Antioxidant effect of the marine algae Chlorella vulgaris against naphthalene-induced oxidative stress in the albino rats. Mol Cell Biochem 303:39–44CrossRef
13.
Zurück zum Zitat Lee HS, Choi CY, Cho C, Song Y (2003) Attenuating effect of chlorella supplementation on oxidative stress and NFkappaB activation in peritoneal macrophages and liver of C57BL/6 mice fed on an atherogenic diet. Biosci Biotechnol Biochem 67:2083–2090CrossRef Lee HS, Choi CY, Cho C, Song Y (2003) Attenuating effect of chlorella supplementation on oxidative stress and NFkappaB activation in peritoneal macrophages and liver of C57BL/6 mice fed on an atherogenic diet. Biosci Biotechnol Biochem 67:2083–2090CrossRef
14.
Zurück zum Zitat Pechanova O, Simko F (2009) Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J Hypertens 27(Suppl 6):S32–S36CrossRef Pechanova O, Simko F (2009) Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J Hypertens 27(Suppl 6):S32–S36CrossRef
15.
Zurück zum Zitat Napoli C, Sica V, de Nigris F et al (2004) Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 148:e5CrossRef Napoli C, Sica V, de Nigris F et al (2004) Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 148:e5CrossRef
16.
Zurück zum Zitat Kitamoto S, Egashira K, Kataoka C et al (2000) Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18:1795–1800CrossRef Kitamoto S, Egashira K, Kataoka C et al (2000) Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18:1795–1800CrossRef
17.
Zurück zum Zitat Siani A, Pagano E, Iacone R et al (2000) Blood pressure and metabolic changes during dietary l-arginine supplementation in humans. Am J Hypertens 13:547–551CrossRef Siani A, Pagano E, Iacone R et al (2000) Blood pressure and metabolic changes during dietary l-arginine supplementation in humans. Am J Hypertens 13:547–551CrossRef
18.
Zurück zum Zitat Mann GE, Yudilevich DL, Sobrevia L (2003) Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183–252 Mann GE, Yudilevich DL, Sobrevia L (2003) Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183–252
19.
Zurück zum Zitat Ast J, Jablecka A, Bogdanski P et al (2010) Evaluation of the antihypertensive effect of l-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring. Med Sci Monit 16:CR266–CR271 Ast J, Jablecka A, Bogdanski P et al (2010) Evaluation of the antihypertensive effect of l-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring. Med Sci Monit 16:CR266–CR271
20.
Zurück zum Zitat De Gennaro Colonna V, Rigamonti A, Fioretti S et al (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 516:253–259CrossRef De Gennaro Colonna V, Rigamonti A, Fioretti S et al (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 516:253–259CrossRef
21.
Zurück zum Zitat Pereira LM, Almeida JR, Mandarim-de-Lacerda CA (2004) Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats. Life Sci 74:1375–1386CrossRef Pereira LM, Almeida JR, Mandarim-de-Lacerda CA (2004) Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats. Life Sci 74:1375–1386CrossRef
22.
Zurück zum Zitat Vijan SG (2009) Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. J Indian Med Assoc 107:178–182 Vijan SG (2009) Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. J Indian Med Assoc 107:178–182
23.
Zurück zum Zitat Suetsuna K, Chen JR (2001) Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar Biotechnol (NY) 3:305–309CrossRef Suetsuna K, Chen JR (2001) Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar Biotechnol (NY) 3:305–309CrossRef
24.
Zurück zum Zitat Katoh M, Egashira K, Mitsui T et al (2000) Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol 32:73–83CrossRef Katoh M, Egashira K, Mitsui T et al (2000) Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol 32:73–83CrossRef
25.
Zurück zum Zitat Zhang H, Park Y, Wu J et al (2009) Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 116:219–230CrossRef Zhang H, Park Y, Wu J et al (2009) Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 116:219–230CrossRef
26.
Zurück zum Zitat Gonzalez W, Fontaine V, Pueyo ME et al (2000) Molecular plasticity of vascular wall during N(G)-nitro-l-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 36:103–109CrossRef Gonzalez W, Fontaine V, Pueyo ME et al (2000) Molecular plasticity of vascular wall during N(G)-nitro-l-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 36:103–109CrossRef
27.
Zurück zum Zitat Fogari R, Zoppi A (2005) Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant? Am J Cardiovasc Drugs 5:211–223CrossRef Fogari R, Zoppi A (2005) Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant? Am J Cardiovasc Drugs 5:211–223CrossRef
28.
Zurück zum Zitat Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC (1999) Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest 104:1131–1137CrossRef Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC (1999) Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest 104:1131–1137CrossRef
29.
Zurück zum Zitat Huang H, Zhou Y, Raju VT et al (2005) Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats. Am J Physiol Renal Physiol 289:F1116–F1122CrossRef Huang H, Zhou Y, Raju VT et al (2005) Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats. Am J Physiol Renal Physiol 289:F1116–F1122CrossRef
Metadaten
Titel
Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats
verfasst von
Su-Ching Yang
Hsin-Yi Yang
Yi-Ching Yang
Hsiang-Chi Peng
Pei-Yin Ho
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 2/2013
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-012-0362-0

Weitere Artikel der Ausgabe 2/2013

European Journal of Nutrition 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.